Utility of human hepatocyte spheroids for evaluation of hepatotoxicity-Reference-Cited by-同舟云学术

Utility of human hepatocyte spheroids for evaluation of hepatotoxicity

Published:2015 Issue:1 Volume:2 Page:41-48
ISSN:2189-115X
Container-title:Fundamental Toxicological Sciences
language:en
Short-container-title:Fundam. Toxicol. Sci.

Author:

Ogihara Takuo¹²,Iwai Hisakazu¹³,Inoue Yukiko¹,Katagi Jun¹⁴,Matsumoto Norihito¹⁴,Motoi-Ohtsuji Makiko¹⁵,Kakiki Motoharu¹⁵,Kaneda Shinya¹⁶,Nagao Takuya¹⁷,Kusumoto Kumiko¹⁸,Ozeki Emiko¹⁹,Jomura Tomoko¹⁹,Tanaka Sho¹¹⁰,Ueda Tadayoshi¹¹¹,Ohta Kunihiro¹¹²,Ohkura Takako¹¹³,Arakawa Hiroshi¹²,Nagai Daichi¹¹⁴

Affiliation:

1. Spheroid Working Group, Safety Evaluation Forum

2. Laboratory of Biopharmaceutics, Faculty of Pharmacy, Takasaki University of Health and Welfare

3. Drug Development Center, Sanwa Kagaku Kenkyusho Co., Ltd.

4. Department of Biology & Pharmacology, Ono Pharmaceutical Co., Ltd.

5. Drug Metabolism and Pharmacokinetics Japan, Tsukuba Research Laboratories, Eisai Co., Ltd.

6. Naruto Research Institute, Otsuka Pharmaceutical Factory, Inc.

7. Environmental Evaluation Business Division, Sumika Chemical Analysis Service, Ltd.

8. Department of Pathology, Osaka City University Medical School

9. Research and Development, Toyo Gosei Co., Ltd.

10. Safety Assessment Unit, Toxicological Laboratory, Public Interest Incorporated Foundation BioSafety Research Center

11. Research & Development Division, Dainippon Sumitomo Pharma Co., Ltd.

12. Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.

13. Clinical Development Division, Maruishi Pharmaceutical, Co., Ltd.

14. Pharmaceutical Research Laboratories, Nippon Kayaku Co., Ltd.

Publisher

Japanese Society of Toxicology

Link

https://www.jstage.jst.go.jp/article/fts/2/1/2_41/_pdf

Reference30 articles.

1. Abernethy, D.R., Greenblatt, D.J. and Shader, R.I. (1985): Imipramine and desipramine disposition in the elderly. J. Pharmacol. Exp. Ther., 232, 183-188.

2. Baraldo, M., Pea, F., Poz, D. and Furlanut, M. (2001): Pharmacokinetics of two oral cyclosporin A formulations in clinically stable heart-transplant patients. Pharmacol. Res., 43, 547-551.

3. Bort, R., Ponsoda, X., Jover, R., Gomez-Lechon, M.J. and Castell, J.V. (1999): Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J. Pharmacol. Exp. Ther., 288, 65-72.

4. Bowsher, R.R., Compton, J.A., Kirkwood, J.A., et al. (1994): Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers. Antimicrob. Agents Chemother., 38, 2134-2142.

5. Crompton, M., Ellinger, H. and Costi, A. (1988): Inhibition by cyclosporin A of a Ca²⁺-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J., 255, 357-360.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically relevant microsystems to study viral infection in the human liver;Frontiers in Microbiology;2022-09-28

2. Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation;Biomaterials and Biosystems;2022-08

3. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project;Frontiers in Toxicology;2021-04-29

4. Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models;Biomedicines;2020-09-23

5. Establishment of a primary human hepatocyte spheroid system for evaluating metabolic toxicity using dacarbazine under conditions of CYP1A2 induction;Drug Metabolism and Pharmacokinetics;2020-04